Overview
While striving to provide excellent clinical care, I also have several research interests:
1. Investigate a neurodevelopmental disorder, Tuberous Sclerosis Complex, which has the potential to provide insight into the pathophysiological mechanism of a neurodegenerative disorders, Alzheimer's Disease.
2. In collaboration with Dr. Cathrine Hoyo, we are investigating an epigenetic mechanism to explain the racial disparities in the development of Alzheimer's disease between underrepresented minorities and European Americans.
3. I am interested establishing biomarkers to diagnose various neurodegenerative diseases.
1. Investigate a neurodevelopmental disorder, Tuberous Sclerosis Complex, which has the potential to provide insight into the pathophysiological mechanism of a neurodegenerative disorders, Alzheimer's Disease.
2. In collaboration with Dr. Cathrine Hoyo, we are investigating an epigenetic mechanism to explain the racial disparities in the development of Alzheimer's disease between underrepresented minorities and European Americans.
3. I am interested establishing biomarkers to diagnose various neurodegenerative diseases.
Current Appointments & Affiliations
Associate Professor of Neurology
·
2024 - Present
Neurology, Behavioral Neurology,
Neurology
Associate Professor in Pathology
·
2024 - Present
Pathology,
Clinical Science Departments
Recent Publications
Cerebrovascular Management Considerations in Patients on AATs.
Journal Article J Clin Med · May 14, 2025 The prevalence of Alzheimer's Disease (AD) is increasing worldwide, with more emergency providers and neurologists expecting to encounter these patients. The paradigm of management of AD is expected to change given the recent approval of anti-amyloid thera ... Full text Link to item CiteDNA methylation of imprint control regions associated with Alzheimer's disease in non-Hispanic Blacks and non-Hispanic Whites.
Journal Article Clin Epigenetics · April 25, 2024 Alzheimer's disease (AD) prevalence is twice as high in non-Hispanic Blacks (NHBs) as in non-Hispanic Whites (NHWs). The objective of this study was to determine whether aberrant methylation at imprint control regions (ICRs) is associated with AD. Differen ... Full text Link to item CiteSkin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
Journal Article JAMA · April 16, 2024 IMPORTANCE: Finding a reliable diagnostic biomarker for the disorders collectively known as synucleinopathies (Parkinson disease [PD], dementia with Lewy bodies [DLB], multiple system atrophy [MSA], and pure autonomic failure [PAF]) is an urgent unmet need ... Full text Link to item CiteRecent Grants
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Intrathecally Administered ALN-APP in Patients with Cerebral Amyloid Angiopathy (CAA)
Clinical TrialPrincipal Investigator · Awarded by Alnylam Pharmaceuticals · 2025 - 2030Automated High-purity Exosome isolation-based AD diagnostics system (AHEADx)
ResearchCo-Principal Investigator · Awarded by National Institute on Aging · 2023 - 2028A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer¿s Disease o
Clinical TrialPrincipal Investigator · Awarded by Biogen MA, Inc. · 2023 - 2027View All Grants
Recent Artistic Works
Real World Implicatinos of Lecanemab Use
Digital Media April 29, 2025 https://www.alzforum.org/news/conference-coverage/leqembi-clinic-early-reports-aria-rates-echo-trialsSpinal Tap procedure
Digital Media April 1, 2022View All Artistic Works
Education, Training & Certifications
Rosalind Franklin University of Medicine and Science, Chicago Medical School ·
2013
M.D.
Rosalind Franklin University of Medicine and Science ·
2008
M.S.